Also known as آسٹیوپوروسس مینجمنٹ
Gastroenterologist
MBBS, FCPS (Gastroenterology)
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine)
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine)
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine), MRCEM
Rheumatologist
M.B.B.S, F.C.P.S. (Medicine), F.C.P.S (Rheumatology), MRCP( UK)
Rheumatologist
M.B.B.S, F.C.P.S. (Medicine), F.C.P.S (Rheumatology), MRCP( UK)
Internal Medicine Specialist
MBBS, FCPS
Internal Medicine Specialist
M.B.B.S., F.C.P.S., MRCP-I (UK), Diploma in Aesthetic Medicine, Diploma in Invasive and Non Invasive Esthetics and Laser
Internal Medicine Specialist
M.B.B.S., F.C.P.S., MRCP-I (UK), Diploma in Aesthetic Medicine, Diploma in Invasive and Non Invasive Esthetics and Laser
Internal Medicine Specialist
M.B.B.S., M.C.P.S
Internal Medicine Specialist
MBBS, European Board Certified (Emergency Medicine)
Gastroenterologist
M.B.B.S. , F.C.P.S. (Gastroenterology)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures